aod9604 clinical trial obesity AOD-9604 was developed from a fragment of human growth hormone because preclinical research suggested effects on fat metabolism. The human evidence did not confirm a consistent, clinically meaningful weight-loss benefit. Development was Capsule Count:30 Capsules Bpc 157 Injection Sites peptide reconstitution
Pay in 4 interest-free payments of $6.83 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4